You are here

  • Home
  • Archive
  • Volume 66, Issue 2
  • Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects

Citation Tools

Article menu

This article has a correction. Please see:

Download PDFPDF
Concise reports
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Iannone F, Trotta F, Monteccuco C on behalf of GISEA (Gruppo Italiano per lo Studio delle Early Arthritis), et al
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects
Annals of the Rheumatic Diseases 2007;66:249-252.